Update on Acute Asthma - PowerPoint PPT Presentation

1 / 37
About This Presentation
Title:

Update on Acute Asthma

Description:

National Asthma Education and Prevention Program (NAEPP) Classification of chronic asthma: ... National Center for Health Statistics, CDC. ED Treatment, 1992-1999 ... – PowerPoint PPT presentation

Number of Views:148
Avg rating:3.0/5.0
Slides: 38
Provided by: carlos228
Category:

less

Transcript and Presenter's Notes

Title: Update on Acute Asthma


1
Update on Acute Asthma
  • Carlos Camargo, MD, DrPH
  • Emergency Medicine, MGH
  • Channing Laboratory, BWH
  • Harvard Medical School

www.emnet-usa.org
2
Outline of Presentation
  • Background
  • NAEPP guidelines
  • Novel therapies
  • Preventive interventions
  • Summary

3
(No Transcript)
4
Definition of Asthma
  • Chronic lung disease characterized by
  • Airway narrowing that is reversible (
    completely) either spontaneously or with
    treatment
  • Airway inflammation
  • Airway hyper-responsiveness to a variety of
    stimuli.
  • Episodic dyspnea with associated wheezing
  • Heterogeneous group with
  • Shortness of breath
  • Wheezing
  • Cough

ATS. ARRD 1987
5
NAEPP Guidelines, 1997
  • National Asthma Education and Prevention Program
    (NAEPP)
  • Classification of chronic asthma
  • Mild intermittent asthma
  • Mild persistent asthma (gt2 days/wk,
    gt2 nights/mo)
  • Moderate persistent asthma
  • Severe persistent asthma
  • Inhaled corticosteroids (ICS) are preferred
    treatment for all patients with persistent asthma

6
Epidemiology
  • 17 - 27 million Americans (6-10 prevalence)
  • 10 million office visits 2 million ED visits
  • 500,000 hospitalizations 5,000 deaths
  • Major cause of school and work absences
  • At least 12 billion per year
  • Increasing burden for years ... but now flat (or
    ? )

7
Asthma Prevalence, 1980-2001
NHIS 2001
11.3
7.3
4.3
8
Asthma Prevalence, 1980-2001
NHIS 2001
11.3
7.3
4.3
9
Asthma Mortality, 1980-1999
10
ED Visits for Asthma, 1992-2000
Visits in thousands
NHAMCS Database
11
MARC
  • Founded 1996
  • Goal To improve care of acute asthma other
    airway disorders
  • Funded by NIH, industry, foundations
  • Emergency Medicine Network
  • www.emnet-usa.org

12
EMNet Sites (137 US sites)
9/22/04
13
Potential for Improving Asthma
  • ED is often used for asthma care
  • 2 million ED visits per year
  • Most asthma hospitalizations begin in the ED
  • Among ED patients (MARC data)
  • 74 adults (63 children) use ED for all
    problem asthma care
  • 45 adults (31 children) receive all asthma Rx
    from ED
  • With PCP 63 61 for problem care 24 25
    for all Rx
  • High-risk population

14
ED Patients with Acute Asthma
15
ED and Hospital Management Goals
  • Correct significant hypoxemia
  • Rapidly reverse airflow obstruction
  • Decrease likelihood of recurrence

NAEPP, 1997
16
ED and Hospital Management Initial Treatment
  • Mild-to-Moderate Exacerbation (PEF gt 50)
  • Oxygen to achieve O2 sat gt 90
  • Inhaled ? 2-agonist by MDI or neb, up to 3 in 1st
    hr
  • Oral corticosteroid if no immediate response or
    if patient recently took oral corticosteroid

NAEPP, 1997
17
ED Treatment, 1992-1999
ED Treatment, 1992-1999
90
80
70
Antiasthmatic
Corticosteroid
60
Antimicrobial
Usage
50
40
30
20
10
0
1993
1994
1995
1996
1997
1998
1999
National Center for Health Statistics, CDC
18
Systemic Steroids at Discharge
P for trend lt0.001
19
ED and Hospital ManagementInitial Treatment
(continued)
  • Severe Exacerbation (PEF lt 50)
  • Oxygen to achieve O2 sat gt 90
  • Inhaled high-dose ?2 -agonist and anticholinergic
    by neb q 20 minutes or continuously for 1 hour
  • Oral corticosteroid

NAEPP, 1997
20
ED and Hospital ManagementInitial Treatment
(continued)
  • Impending or Actual Respiratory Arrest
  • Intubation and mech ventilation with 100 O2
  • Nebulized ?2-agonist and anticholinergic
  • IV corticosteroid
  • Admit to hospital intensive care

NAEPP, 1997
21
2002 Update on Selected Topics
  • Antibiotics not recommended for acute asthma
  • ICS are preferred treatment for children of all
    ages with persistent asthma
  • ICS long-acting ?-agonist is the preferred
    treatment for moderate or severe persistent
    asthma in individuals age 6 and older

NAEPP, 2002
22
Dual Therapy with ICS LABA (weeks)
23
Dual Therapy with ICS LABA (days)
24
Novel Therapies in the ED
  • IV magnesium
  • Heliox
  • IV leukotriene modifiers

www.emnet-usa.org
25
IV Mg for Acute Asthma Admit Rate
26
Heliox for Severe Acute Asthma PEF
27
IV Montelukast for Acute Asthma FEV1
28
ED-Initiated Preventive Interventions
  • High-risk population
  • Use of ED for problem asthma care asthma Rx
  • What interventions are feasible in the ED
    setting?
  • Examples from MARC
  • ICS initiation at discharge from ED
  • Asthma education programs
  • Bridging the gap between ED primary asthma care

29
Initiation of ICS at Discharge

30
ICS after the ED -- Relapse at 20-24 Days
31
Prevention of Repeat ED Visits
32
Prevention of Fatal Asthma
Suissa Ernst, JACI 2001.
33
National Asthma Educator Certification Board
  • Mission Statement
  • To promote optimal asthma management and
  • quality of life among individuals with asthma,
  • their families and communities, by advancing
  • excellence in asthma education through the
  • Certified Asthma Educator process.

www.naecb.org
34
(No Transcript)
35
Follow-up with PCP
  • Philadelphia study
  • randomized trial, 1 center, n178
  • 25 intervention (free meds, taxi vouchers, 48-hr
    call)
  • f/u with PCP usual care (29) vs. intervention
    (46), p0.02
  • RR1.6 (95CI, 1.1-2.4)
  • EMF Center of Excellence Award
  • Recently completed RCT at 9 EMNet sites
  • 1 month 50 increase in PCP follow-up (ACEP
    2001)

Baren et al, Ann Emerg Med 2001
36
Follow-up with PCP
  • Philadelphia study
  • randomized trial, 1 center, n178
  • 25 intervention (free meds, taxi vouchers, 48-hr
    call)
  • f/u with PCP usual care (29) vs. intervention
    (46), p0.02
  • RR1.6 (95CI, 1.1-2.4)
  • EMF Center of Excellence Award
  • Recently completed RCT at 9 EMNet sites
  • 1 month 50 increase in PCP follow-up (ACEP
    2001)
  • 6 and 12 months no diff in clinical outcomes
    (ACEP 2002)
  • Next steps facilitated referral to
    specialists?

37
Summary
  • Asthma epidemiology
  • NAEPP guidelines
  • 1997 O2 prn, inhaled ß-agonist antichol,
    systemic steroids
  • 2002 ICS for children of all ages with
    persistent asthma
  • ICS LABA for age 6 with moderate-severe
    persistent
  • Novel treatments severe exacerbations only
  • Prevention at all clinical encounters!
  • Start ICS at ED discharge consider ICS LABA
  • Asthma education (brief) consider outpatient
    session
  • Arrange continuing care consider referral to
    specialist
Write a Comment
User Comments (0)
About PowerShow.com